US Patent Issued to Nuclidium, University of Basel on Jan. 20 for "High purity copper radiopharmaceutical compositions and diagnostic and therapeutic uses thereof" (Swiss, German Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,885, issued on Jan. 20, was assigned to Nuclidium AG (Basel, Switzerland) and University of Basel (Basel, Switzerland).

"High purity copper radiopharmaceutical compositions and diagnostic and therapeutic uses thereof" was invented by Leila Jaafar-Thiel (Erlangen, Germany), Melpomeni Fani (Basel, Switzerland), Jacopo Millul (Basel, Switzerland) and Francesco De Rose (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the field of nuclear imaging and therapy, and more specifically to high purity copper radiotracer compositions useful in imaging, such as positron emission tomography (PET) and single-photon emission ...